Latest Financing News

New Murchison Gold Limited has transitioned from explorer to producer with mining underway at its Crown Prince project, backed by a $12 million capital raise and promising high-grade drilling results.

Calix Limited has secured a $44.9 million grant from ARENA to build a pioneering Green Iron Demonstration Plant using its ZESTY technology, aiming to produce 30,000 tonnes of low-emission iron annually and advance Australia’s green steel ambitions.

Adisyn Ltd has made significant strides in developing low-temperature graphene semiconductor interconnects, commissioning a new Atomic Layer Deposition system and securing a major managed IT services contract, while maintaining a strong cash position.

Deep Yellow Limited reported a quarterly operating cash outflow of A$6.3 million but ended June 2025 with a strong cash position of A$217 million, providing a runway of 24 quarters at current spending levels.

Deep Yellow Limited reports significant progress at its flagship Tumas uranium project in Namibia and successful pilot testing at Mulga Rock in Australia, supported by a robust cash position of A$217.4 million.

Tungsten Mining NL (ASX – TGN) highlights its position as a key supplier of ethically sourced tungsten outside China, leveraging one of the world’s largest resource bases amid tightening global supply and rising prices.

Mantle Minerals has received conversion notices for over half of its outstanding convertible notes, prompting a shareholder vote in September to decide on converting $742,000 of debt into shares with attached options.

Rimfire Pacific Mining is advancing its position as a leading scandium explorer in Australia’s Fifield district, with plans for new Mineral Resource Estimates and a $3.5 million capital raise to fund drilling and exploration. Joint ventures with Golden Plains Resources have been reinstated, underpinning a strategic push in a critical mineral market facing supply constraints.

Amplia Therapeutics has launched a $27.5 million capital raising to advance its lead drug Narmafotinib, a promising FAK inhibitor showing superior efficacy in pancreatic cancer trials. The funds will support ongoing and new clinical studies, positioning the company for pivotal regulatory milestones.

Lake Resources has raised $2.1 million through its At-the-Market facility by issuing 65 million shares to Acuity Capital, while extending the agreement to 2031 to support its Kachi Project and working capital needs.

Highfield Resources has entered a significant non-binding agreement with China’s Qinghai Salt Lake Industry for a US$300 million equity injection, aiming to fast-track its Muga potash mine development and expand its global footprint.

Antares Metals has released an updated investor presentation detailing its Queens Gift Project's historical resource and highlighting promising copper and uranium exploration targets in the prolific Mt Isa region.